DrugPatentWatch Database Preview
Taro Pharm Inds Ltd Company Profile
What is the competitive landscape for TARO PHARM INDS LTD, and what generic alternatives to TARO PHARM INDS LTD drugs are available?
TARO PHARM INDS LTD has twenty approved drugs.
There are two US patents protecting TARO PHARM INDS LTD drugs.
There are ten patent family members on TARO PHARM INDS LTD drugs in seven countries and nine supplementary protection certificates in four countries.
Summary for Taro Pharm Inds Ltd
| International Patents: | 10 |
| US Patents: | 2 |
| Tradenames: | 12 |
| Ingredients: | 10 |
| NDAs: | 20 |
Drugs and US Patents for Taro Pharm Inds Ltd
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Taro Pharm Inds Ltd | ACETAMINOPHEN | acetaminophen | SUPPOSITORY;RECTAL | 018337-002 | Approved Prior to Jan 1, 1982 | OTC | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Taro Pharm Inds Ltd | INFANTS' FEVERALL | acetaminophen | SUPPOSITORY;RECTAL | 018337-004 | Aug 26, 1992 | OTC | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Taro Pharm Inds Ltd | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | CREAM;TOPICAL | 040039-001 | Nov 26, 1997 | AT | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Taro Pharm Inds Ltd | TOPICORT | desoximetasone | CREAM;TOPICAL | 017856-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ➤ Sign Up | ➤ Sign Up | |||||
| Taro Pharm Inds Ltd | OVIDE | malathion | LOTION;TOPICAL | 018613-001 | Aug 2, 1982 | AT | RX | Yes | Yes | 7,560,445 | ➤ Sign Up | Y | Y | ➤ Sign Up | |
| Taro Pharm Inds Ltd | TOPICORT | desoximetasone | OINTMENT;TOPICAL | 074286-001 | Jun 7, 1996 | AB | RX | No | Yes | ➤ Sign Up | ➤ Sign Up | ||||
| Taro Pharm Inds Ltd | HYDROCORTISONE AND ACETIC ACID | acetic acid, glacial; hydrocortisone | SOLUTION/DROPS;OTIC | 088759-001 | Mar 4, 1985 | AT | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Paragraph IV (Patent) Challenges for TARO PHARM INDS LTD drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Topical Spray | 0.25% | ➤ Subscribe | 2013-12-18 |
| ➤ Subscribe | Topical Lotion | 0.5% | ➤ Subscribe | 2011-03-16 |
International Patents for Taro Pharm Inds Ltd Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Israel | 188512 | ➤ Sign Up |
| European Patent Office | 1898707 | ➤ Sign Up |
| Japan | 5474347 | ➤ Sign Up |
| Japan | 2013032405 | ➤ Sign Up |
| Canada | 2612578 | ➤ Sign Up |
| Japan | 2009500422 | ➤ Sign Up |
| China | 101287374 | ➤ Sign Up |
| Country | Patent Number | Estimated Expiration |
Supplementary Protection Certificates for Taro Pharm Inds Ltd Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1586316 | SPC/GB11/054 | United Kingdom | ➤ Sign Up | PRODUCT NAME: BROMFENAC 2-AMINO-3-(4-BROMOBENZOYL)PHENYLACETIC ACID OR A PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF OR A HYDRATE THEREOF; REGISTERED: UK EU/1/11/692/001 20110523 |
| 0809498 | SPC/GB10/012 | United Kingdom | ➤ Sign Up | PRODUCT NAME: A COMBINATION OF ACYCLOVIR AND HYDROCORTISONE; REGISTERED: UK PL18191/0001-0001 20091112 |
| 0058146 | 2001C/045 | Belgium | ➤ Sign Up | PRODUCT NAME: DICHLORHYDRATE DE LEVOCETIRIZINE; NAT RER. NO/DATE: 194 IS 90 F3 20011022; FIRST REG.: DE 49903.00.00 20010103 |
| 1110543 | SPC/GB08/005 | United Kingdom | ➤ Sign Up | SUPPLEMENTARY PROTECTION CERTIFICATE NO SPC/GB08/005 GRANTED TO MERCK SHARP + DOHME CORP. IN RESPECT OF THE PRODUCT DESLORATADINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, IN COMBINATION WITH PSEUDOEPHEDRINE OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT OR ESTER, THE GRANT OF WHICH WAS ADVERTISED IN JOURNAL NO 6322 DATED 21 JULY 2010 HAS HAD ITS MAXIMUM PERIOD OF DURATION CORRECTED, SUBJECT TO THE PAYMENT OF THE PRESCRIBED FEES IT WILL EXPIRE ON 31 JULY 2022. |
| 0152897 | 2001C/013 | Belgium | ➤ Sign Up | PRODUCT NAME: DESLORATADINE; REGISTRTION NO/DATE: EU/1/00/160/010 20010115 |
| 0663828 | C300085 | Netherlands | ➤ Sign Up | PRODUCT NAME: LEVOCETIRIZINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER LEVOCETIRINE DIHYDROCHLORIDE; NAT. REGISTRATION NO/DATE: RVG 26770 20011009; FIRST REGISTRATION: DE 49903.00.00 AND 49904.00.00 20010103 |
| 0152897 | SPC/GB01/012 | United Kingdom | ➤ Sign Up | PRODUCT NAME: DESLORATADINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTERED: UK EU/1/00/157/001-013 20010115; UK EU/1/00/158/001-013 20010115; UK EU/1/00/159/001-013 20010115; UK EU/1/00/160/001-013 20010115; UK EU/1/00/161/001-013 20010115 |
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
